chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Dyspnoea, Pain in extremity, Pleurisy
Clinical narrative: it was hard to breathe patient went into the doctor; Pleurisy started on Monday dated patient thought it was a pulled muscle.; extreme thumb and wrist pain in patient left wrist; extreme thumb and wrist pain in patient left wrist; This is a spontaneous report from a contactable consumer (reported for himself). A 41-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: ER2613/Batch number was not reported), via an unspecified route of administration, administered in arm left on 16Apr2021 at 00:15 (at the age of 41-years-old) as dose number unknown, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient has no reported allergies. It was reported that pleurisy started on Monday 19Apr2021 patient thought it was a pulled muscle. Patient also had extreme thumb and wrist pain in his left wrist started on Monday as well but went away the very next day completely gone just as fast as it appeared so no way it was injury related. Patient thought his chest was getting better on Tuesday 20Apr2021 then when he woke up on Wednesday 21Apr2021 and it was hard to breathe. The reporter stated the events result in Doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of events included treatment with Steroids / Antibiotics. The outcome of the event extreme thumb and wrist pain in patient left wrist was resolved on 20Apr2021 and other events was resolving.  No follow-up attempts are possible. No further information is expected.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chest pain, Pain in extremity, Vaccination site erythema, Vaccination site pain
Clinical narrative: Red, swelling, pain, rash at injection site; Red, swelling, pain, rash at injection site; Red, swelling, pain, rash at injection site; Red, swelling, pain, rash at injection site; Thought he was having a heart attack, arm, shoulder, chest pain; Thought he was having a heart attack, arm, shoulder, chest pain; Thought he was having a heart attack, arm, shoulder, chest pain; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 65-years-old male patient received bnt162b2 (BNT162B2, Pfizer-BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number EN6205; Expiration Date: 21Jun2021), dose 2 via an unspecified route of administration, administered in Arm Left on 01Mar2021 17:00 as DOSE 2, SINGLE for covid-19 immunisation (Age at vaccination 65 years). Historical vaccine includes bnt162b2 (BNT162B2, Pfizer-BioNTech Covid-19 mRNA Vaccine, Solution for injection, Lot Number: EM9809; Expiry Date: 30Jun2021), dose 1 on 08Feb2021 for covid-19 immunisation. Medical history included cardiac disorder from an unknown date and unknown if ongoing (Heart Condition), Caller mentioned this during his indication for the vaccine. Denied any medical conditions relevant to report; no further information provided by caller about this condition. There were no concomitant medications. Caller denies any medical conditions, medications, labs, testing, or treatments relevant to report. Non prior Vaccinations (within 4 weeks). Family Medical History Relevant to AE was none. On an unspecified date in 2021 patient thought he was having a heart attack, arm, shoulder, chest pain, on 11Apr2021 red, swelling, pain, rash at injection site (vaccination site) and asked if this is norma. Event Red, swelling, pain, rash at injection site was reported as worsened. Emergency visit required for event. Caller states he went to the Emergency Room because he was having pain in his left arm, shoulder, and pain in his chest. States he had a procedure about a month ago and thought it might be from that. Says he hadn't noticed the rash to his arm until after his Emergency Room visit; his daughter pointed it out. States that he thought he was having a heart attack and that's why he went to the Emergency Room. The outcome for thought he was having a heart attack, arm, shoulder, chest pain, was unknown, and outcome for vaccination site red, swelling, pain and rash was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site rash, Vaccination site swelling
Clinical narrative: Red, swelling, pain, rash at injection site; Red, swelling, pain, rash at injection site; Red, swelling, pain, rash at injection site; Red, swelling, pain, rash at injection site; Thought he was having a heart attack, arm, shoulder, chest pain; Thought he was having a heart attack, arm, shoulder, chest pain; Thought he was having a heart attack, arm, shoulder, chest pain; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 65-years-old male patient received bnt162b2 (BNT162B2, Pfizer-BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number EN6205; Expiration Date: 21Jun2021), dose 2 via an unspecified route of administration, administered in Arm Left on 01Mar2021 17:00 as DOSE 2, SINGLE for covid-19 immunisation (Age at vaccination 65 years). Historical vaccine includes bnt162b2 (BNT162B2, Pfizer-BioNTech Covid-19 mRNA Vaccine, Solution for injection, Lot Number: EM9809; Expiry Date: 30Jun2021), dose 1 on 08Feb2021 for covid-19 immunisation. Medical history included cardiac disorder from an unknown date and unknown if ongoing (Heart Condition), Caller mentioned this during his indication for the vaccine. Denied any medical conditions relevant to report; no further information provided by caller about this condition. There were no concomitant medications. Caller denies any medical conditions, medications, labs, testing, or treatments relevant to report. Non prior Vaccinations (within 4 weeks). Family Medical History Relevant to AE was none. On an unspecified date in 2021 patient thought he was having a heart attack, arm, shoulder, chest pain, on 11Apr2021 red, swelling, pain, rash at injection site (vaccination site) and asked if this is norma. Event Red, swelling, pain, rash at injection site was reported as worsened. Emergency visit required for event. Caller states he went to the Emergency Room because he was having pain in his left arm, shoulder, and pain in his chest. States he had a procedure about a month ago and thought it might be from that. Says he hadn't noticed the rash to his arm until after his Emergency Room visit; his daughter pointed it out. States that he thought he was having a heart attack and that's why he went to the Emergency Room. The outcome for thought he was having a heart attack, arm, shoulder, chest pain, was unknown, and outcome for vaccination site red, swelling, pain and rash was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Blood pressure measurement, Cardiac stress test, Chest discomfort, Cold sweat
Clinical narrative: nausea; terrible cold sweat; Numbness tingling left side for days; Numbness tingling left side for days; light headed; odd breathing; chest tightness; blood pressure jump; This is a spontaneous report from a contactable consumer(patient). A 71-years-old female non-pregnant patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EN6201), via an unspecified route of administration in the left arm on 16Feb2021 13:00 as a single dose for COVID-19 immunization (at the age of 71-years-old). Facility type vaccine was School or Student Health Clinic. Medical history included hypothyroidism and arthritis from an unknown date and unknown if ongoing. There were no known allergies. Concomitant medication(s) included levothyroxine, acetylsalicylic acid (ASPIRIN 81), colecalciferol (D3), cyanocobalamin (B12-VITAMIIN), biotin and lactobacillus acidophilus (PROBIO) taken for an unspecified indication, start and stop date were not reported. Historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EL9262), via an unspecified route of administration in the left arm on 26Jan2021 13:00 as a single dose for COVID-19 immunization (at the age of 71-years-old). The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced numbness tingling left side for days, light-headed, chest tightness, blood pressure jump, odd breathing on 17Feb2021. ER tests found nothing. Then next AM (18Feb2021) nausea & terrible cold sweat. Ok ever since. No heart history. Adverse events resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The patient underwent lab tests and procedures which included blood pressure measurement: jump, cardiac stress test: unknown result, computerized tomogram: unknown result, electrocardiogram: unknown result, x-ray: unknown result on an unspecified date. The clinical outcome for events was recovered on an unspecified date in 2021.  No follow-up attempts are possible. No further information is expected.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram, Dizziness, Dyspnoea, Electrocardiogram, Hypoaesthesia
Clinical narrative: nausea; terrible cold sweat; Numbness tingling left side for days; Numbness tingling left side for days; light headed; odd breathing; chest tightness; blood pressure jump; This is a spontaneous report from a contactable consumer(patient). A 71-years-old female non-pregnant patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EN6201), via an unspecified route of administration in the left arm on 16Feb2021 13:00 as a single dose for COVID-19 immunization (at the age of 71-years-old). Facility type vaccine was School or Student Health Clinic. Medical history included hypothyroidism and arthritis from an unknown date and unknown if ongoing. There were no known allergies. Concomitant medication(s) included levothyroxine, acetylsalicylic acid (ASPIRIN 81), colecalciferol (D3), cyanocobalamin (B12-VITAMIIN), biotin and lactobacillus acidophilus (PROBIO) taken for an unspecified indication, start and stop date were not reported. Historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EL9262), via an unspecified route of administration in the left arm on 26Jan2021 13:00 as a single dose for COVID-19 immunization (at the age of 71-years-old). The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced numbness tingling left side for days, light-headed, chest tightness, blood pressure jump, odd breathing on 17Feb2021. ER tests found nothing. Then next AM (18Feb2021) nausea & terrible cold sweat. Ok ever since. No heart history. Adverse events resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The patient underwent lab tests and procedures which included blood pressure measurement: jump, cardiac stress test: unknown result, computerized tomogram: unknown result, electrocardiogram: unknown result, x-ray: unknown result on an unspecified date. The clinical outcome for events was recovered on an unspecified date in 2021.  No follow-up attempts are possible. No further information is expected.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Paraesthesia, X-ray
Clinical narrative: nausea; terrible cold sweat; Numbness tingling left side for days; Numbness tingling left side for days; light headed; odd breathing; chest tightness; blood pressure jump; This is a spontaneous report from a contactable consumer(patient). A 71-years-old female non-pregnant patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EN6201), via an unspecified route of administration in the left arm on 16Feb2021 13:00 as a single dose for COVID-19 immunization (at the age of 71-years-old). Facility type vaccine was School or Student Health Clinic. Medical history included hypothyroidism and arthritis from an unknown date and unknown if ongoing. There were no known allergies. Concomitant medication(s) included levothyroxine, acetylsalicylic acid (ASPIRIN 81), colecalciferol (D3), cyanocobalamin (B12-VITAMIIN), biotin and lactobacillus acidophilus (PROBIO) taken for an unspecified indication, start and stop date were not reported. Historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot Number: EL9262), via an unspecified route of administration in the left arm on 26Jan2021 13:00 as a single dose for COVID-19 immunization (at the age of 71-years-old). The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced numbness tingling left side for days, light-headed, chest tightness, blood pressure jump, odd breathing on 17Feb2021. ER tests found nothing. Then next AM (18Feb2021) nausea & terrible cold sweat. Ok ever since. No heart history. Adverse events resulted in doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The patient underwent lab tests and procedures which included blood pressure measurement: jump, cardiac stress test: unknown result, computerized tomogram: unknown result, electrocardiogram: unknown result, x-ray: unknown result on an unspecified date. The clinical outcome for events was recovered on an unspecified date in 2021.  No follow-up attempts are possible. No further information is expected.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Dyspnoea, Pain in extremity, Pharyngeal swelling
Clinical narrative: difficulty breathing; Light pains in my chest and arms felt like getting stabbed by a nail; Light pains in my chest and arms felt like getting stabbed by a nail; Swelling of my throat; This is a spontaneous report from a contactable consumer (patient himself). A 18-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in left arm on 22Apr2021 10:45 (age at vaccination: 18 years) as DOSE 1, SINGLE for covid-19 immunisation. The patient's medical history included allergy to pollen and sulfa drugs. The patient's concomitant medications were not reported. The patient received the vaccine in a student health clinic. The patient did not receive any other vaccine in four weeks. On 22Apr2021 11:00, the patient experienced difficulty breathing, light pains in my chest and arms felt like getting stabbed by a nail only on the opposite side of the vaccine arm, swelling of throat. The adverse events resulted in physician's office visit. The patient received Benadryl injection as treatment for the adverse events. The patient did not have covid prior vaccination nor was tested for covid post vaccination. The outcome of the events was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Balance disorder, Blood test, Body temperature, Dysstasia, Gait disturbance
Clinical narrative: Hands were numb, legs were numb down to the feet; he couldn't walk or stand; Fever; couldn't walk or stand; he had no balance; This is a spontaneous report from a contactable consumer (patient). A 63-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-119 VACCINE, Solution for injection, Lot number: ER8731) via unknown route of administration on 20Apr2021 11:30 (age at vaccination 63-year-old) as dose 2 single in left arm for COVID-19 immunization. Medical history included ongoing chronic kidney failure (states at least 8 years ago. patient reported 5 stages of kidney failure, with the most severe stage as 5, and he reports he is in Stage 4), Covid in Dec2020 (patient states he had some type of infusion, clarified as a monoclonal infusion, while he had Covid, because if not, he would not have had a good outcome). No Prior Vaccinations (within 4 weeks). Family history reported as his mother who was 86 years old, had both Pfizer vaccines with no reactions. Concomitant medications reported that he was on 9 medications that he has taken for 30 years. Patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-119 VACCINE) on 23Mar2021 10:30 AM for COVID-19 immunization and also took Flu vaccine with which his stomach felt nauseated, also he did not feel great. It was reported that immediately after the vaccine he reported his hands were numb, his legs were numb from he knees down, his feet were numb and he had no balance, couldn't stand without support and he felt like his feet were not underneath him. patient stated he went to the emergency room again, after the second vaccine, and he couldn't walk and he was put in a wheelchair on 20Apr2021 12:00. Reclarified, he had an MRI of the brain, blood tests and because of his balance issues and difficulty standing, they wanted to rule out a stroke. patient stated he did have an MRI of the brain and the results were normal. patient stated he had trouble for the rest of the day walking and had to hang onto walls to go upstairs or move around. patient reported that he had a fever of around 100 degrees on 20Apr2021 12:00. patient stated he was able to eat and drink and was not dehydrated. patient reported that he was on 9 medications that he has taken for 30 years, and he does not think they are relevant to the report. patient was assured that any symptoms or side effects were normal with the covid vaccine. patient was told he may be experiencing more side effects because of his, history of kidney failure. Patient visited Emergency Room for adverse events. The outcome of events was unknown.  No follow-up attempts are needed; No further information is expected.
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia, Magnetic resonance imaging head, Pyrexia
Clinical narrative: Hands were numb, legs were numb down to the feet; he couldn't walk or stand; Fever; couldn't walk or stand; he had no balance; This is a spontaneous report from a contactable consumer (patient). A 63-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-119 VACCINE, Solution for injection, Lot number: ER8731) via unknown route of administration on 20Apr2021 11:30 (age at vaccination 63-year-old) as dose 2 single in left arm for COVID-19 immunization. Medical history included ongoing chronic kidney failure (states at least 8 years ago. patient reported 5 stages of kidney failure, with the most severe stage as 5, and he reports he is in Stage 4), Covid in Dec2020 (patient states he had some type of infusion, clarified as a monoclonal infusion, while he had Covid, because if not, he would not have had a good outcome). No Prior Vaccinations (within 4 weeks). Family history reported as his mother who was 86 years old, had both Pfizer vaccines with no reactions. Concomitant medications reported that he was on 9 medications that he has taken for 30 years. Patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-119 VACCINE) on 23Mar2021 10:30 AM for COVID-19 immunization and also took Flu vaccine with which his stomach felt nauseated, also he did not feel great. It was reported that immediately after the vaccine he reported his hands were numb, his legs were numb from he knees down, his feet were numb and he had no balance, couldn't stand without support and he felt like his feet were not underneath him. patient stated he went to the emergency room again, after the second vaccine, and he couldn't walk and he was put in a wheelchair on 20Apr2021 12:00. Reclarified, he had an MRI of the brain, blood tests and because of his balance issues and difficulty standing, they wanted to rule out a stroke. patient stated he did have an MRI of the brain and the results were normal. patient stated he had trouble for the rest of the day walking and had to hang onto walls to go upstairs or move around. patient reported that he had a fever of around 100 degrees on 20Apr2021 12:00. patient stated he was able to eat and drink and was not dehydrated. patient reported that he was on 9 medications that he has taken for 30 years, and he does not think they are relevant to the report. patient was assured that any symptoms or side effects were normal with the covid vaccine. patient was told he may be experiencing more side effects because of his, history of kidney failure. Patient visited Emergency Room for adverse events. The outcome of events was unknown.  No follow-up attempts are needed; No further information is expected.
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Chest pain, Dyspepsia, Influenza like illness, Throat irritation
Clinical narrative: flu like symptoms; I felt immense chest and throat burning (seemed like heart burn); I felt immense chest and throat burning (seemed like heart burn); I felt immense chest and throat burning (seemed like heart burn); painful back pain around the thoracic spine; This is a spontaneous report from a contactable consumer (patient). A 36-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: EW0164) via an unspecified route of administration, administered in Arm Left on 18Apr2021 08:00 (at the age of 36 years old) as dose 2, single for COVID-19 immunisation at hospital. Medical history included gastritis, asthma, depression, and seasonally allergies, all from an unknown date and unknown if ongoing. Concomitant medication(s) included bupropion hcl (BUPROPION HCL), citalopram (CITALOPRAM), both taken for depression, start and stop date were not reported. Patient historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: ER8734) via an unspecified route of administration, administered in Arm Left on 28Mar2021 08:00 (at the age of 35 years old) as single for COVID-19 immunisation. Patient did not received other vaccine in four weeks of COVID vaccine. Patient did not have COVID prior to vaccination. The patient experienced flu like symptoms, i felt immense chest and throat burning, painful back pain around the thoracic spine on 19Apr2021 12:00. Reported as, adverse event revived 2nd dose of Pfizer COVID-19 vaccine and within 12 hours experienced flu like symptoms which all seemed normal based on CDC symptom reports. However, about noon the next day I felt immense chest and throat burning (seemed like heart burn) and painful back pain around the thoracic spine. It took almost 3 hours for it to subside even after taking antacid (tums) for relief. Patient currently taking antidepressants (Bupropion HCL one dose in morning and Citalopram one dose at night) and wonder if the vaccine caused a reaction to the antidepressants. Therapeutic measures were taken as a result of i felt immense chest and throat burning (seemed like heart burn), painful back pain around the thoracic spine. Patient did not tested for COVID post vaccination. Outcome of all the events were recovered on Apr2021.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Depressed mood, Fatigue, Influenza like illness, Pain
Clinical narrative: Second shot got caller down for three days.; She was weak; fatigued; flu-like symptoms; aching all day; This is a spontaneous report from a contactable consumer (patient) or other non hcp. A 66-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EN6207; Expiration Date: 31Jul2021), via an unspecified route of administration on 19Mar2021 as DOSE 2, SINGLE for covid-19 immunisation. Medical history included pain from 26Feb2021 to 03Mar2021 (Recovered completely), influenza like illness from 26Feb2021 to 03Mar2021 (Recovered completely). The patient's concomitant medications were not reported. The patient experienced second shot got caller down for three days, she was weak, fatigued and flu-like symptoms on an unspecified date, aching all day on 20Mar2021. Outcome of the events Second shot got caller down for three days, She was weak, fatigued and flu-like symptoms was unknown and for aching all day was Recovered on 22MAR2021.  Follow up#01: This is a spontaneous report received from a contactable consumer.  Follow up#02: This is a spontaneous report received from a contactable consumer.  No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Cardiac disorder, Heart rate, Heart rate irregular
Clinical narrative: Heart problem; Severe irregular heartbeat; This is a spontaneous report from a Pfizer sponsored program. A contactable female consumer reported that: A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date in 2021 as a single dose for COVID-19 immunisation. The patient's medical history was and concomitant medications were not reported. On unspecified date, the patient experienced heart problem, severe irregular heartbeat. The consumer stated that she received the 1st dose three weeks ago and also had a heart problem and had severe irregular heartbeat. Her cardiologist prescribed her a new medication and she did not mention what's the name of the medication. She wanted to know if that would have an effect with the vaccination as she was scheduled to receive her 2nd dose on 24Apr2021. The patient underwent lab tests and procedures which included heartbeat: irregular on an unspecified date. Therapeutic measures were taken as a result of heart problem, severe irregular heartbeat. The outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Heart rate, Heart rate increased, Swelling
Clinical narrative: Noon next day increased heart rate over 100bpm,; then extreme swelling and pain underarm, so much swelling I could not lay my arm next to my body.; then extreme swelling and pain underarm,; This is a spontaneous report from a contactable consumer, the patient. This 49-year-old non-pregnant female patient reported that she received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EW0161) via unspecified route in the left arm on 20Apr2021 at 14:30 (at the age of 49-years-old) as a single dose for COVID-19 immunization. Patient had no medical history. Patient had known allergy to Codein. Patient did not have COVID prior to vaccination. No other vaccines were received in four weeks prior to COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: ER8732) via unspecified route on 30Mar2021 at 15:15 (at the age of 49-years-old) as a single dose for COVID-19 immunization. Concomitant medication included ibuprofen. On 21Apr2021 at 12:00 (Noon next day), patient experienced increased heart rate over 100bpm, then extreme swelling and pain underarm, so much swelling she could not lay her arm next to her body. Pain was unrelieved with pain meds. Pain has subsided, swelling not yet. No treatment was received for the events increased heart rate over 100 bpm and swelling. The outcome of swelling was not recovered, while of other events was recovering. Patient was not tested for COVID post vaccination.
Sex: M
Vaccine: COVID19
Symptoms: Burning sensation, Hypoaesthesia, Rash
Clinical narrative: numbness in my shoulder that the shot was given in and a burning sensation sometimes; numbness in my shoulder that the shot was given in and a burning sensation sometimes; rash; This is a spontaneous report from a contactable consumer (patient). A 69-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: Unknown), via an unspecified route of administration on 21Feb2021, as dose 2, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date in Feb2021, after the second dose of vaccine, the patient experienced numbness in his shoulder that the shot was given in and a burning sensation sometimes, motor skills were all there, it was just that tight up the knot, numb sensation from the shoulder down to the elbow sometimes. Also, on an unspecified date in Feb2021, after the second dose of vaccine, patient also had a rash, but it went away. The events were reported as non-serious. The clinical outcome for the event rash was resolved on an unspecified date in 2021 and the clinical outcome of all other events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Heart rate, Heart rate increased
Clinical narrative: Increased heart rate; Shortness of breath; This is a spontaneous report from a contactable consumer (patient) reported herself. A 33-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection; Lot number: ER8729, Expiration date: Unknown), via an unspecified route of administration, in left arm on 23Apr2021 at 14:30 (at the age of 33-years-old) as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: Eco0150, Expiration date: Unknown), via an unspecified route of administration in right arm on 02Apr2021 at 14:30 as dose 1, single (at the age of 33 years-old) as for covid-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medications within 2 weeks of vaccination. The patient experienced Increased heart rate and shortness of breath on 23Apr2021 at 17:30. The patient underwent lab tests and procedures and which included heart rate: Increased on 23Apr2021. Patient did not receive any treatment for the events. The outcome of the events was unknown.  No follow-up attempts are needed. No further information is expected.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Diarrhoea, Irritable bowel syndrome, Vaccination site discharge, Vaccination site infection
Clinical narrative: Developed an infection with pus discharge in my left bicep where the injection was given; Developed an infection with pus discharge in my left bicep where the injection was given; Developed an infection with pus discharge in my left bicep where the injection was given; abdominal pain; diarrhea; IBS-M; This is a spontaneous report from a contactable consumer (Patient). A 31-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EW0164), dose 1 via an unspecified route of administration, administered in Arm Left on 15Apr2021 at 17:00 (at the age of 31 year) as dose 1, single for COVID-19 immunisation at Public Health Clinic/ Medical history included asthma and ongoing irritable bowel syndrome. Patient had known allergies to Augmentin, Biaxin. No other vaccine in four weeks. No covid prior vaccination. No covid tested post vaccination. Concomitant medication(s) included cetirizine hydrochloride, pseudoephedrine hydrochloride (ZYRTEC-D) and almasilate (GELUSIL [ALMASILATE]). The patient previously took augmentin [amoxicillin;clavulanic acid] and biaxin and experienced drug hypersensitivity. On 15Apr2021 at 23:00, patient experienced severe abdominal pain, diarrhea, worst abdominal pain that patient have ever had and patient have IBS-M that was well controlled. This happened within 6 hours of the vaccine. Developed an infection with pus discharge in left bicep where the injection was given. AE resulted in Doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of adverse events and included treatment Anti-diarrheal, anti-spasmodic, antibiotic. The outcome of events was recovered with sequel.  No follow-up attempts are possible. No further information is expected.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pustule
Clinical narrative: Developed an infection with pus discharge in my left bicep where the injection was given; Developed an infection with pus discharge in my left bicep where the injection was given; Developed an infection with pus discharge in my left bicep where the injection was given; abdominal pain; diarrhea; IBS-M; This is a spontaneous report from a contactable consumer (Patient). A 31-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EW0164), dose 1 via an unspecified route of administration, administered in Arm Left on 15Apr2021 at 17:00 (at the age of 31 year) as dose 1, single for COVID-19 immunisation at Public Health Clinic/ Medical history included asthma and ongoing irritable bowel syndrome. Patient had known allergies to Augmentin, Biaxin. No other vaccine in four weeks. No covid prior vaccination. No covid tested post vaccination. Concomitant medication(s) included cetirizine hydrochloride, pseudoephedrine hydrochloride (ZYRTEC-D) and almasilate (GELUSIL [ALMASILATE]). The patient previously took augmentin [amoxicillin;clavulanic acid] and biaxin and experienced drug hypersensitivity. On 15Apr2021 at 23:00, patient experienced severe abdominal pain, diarrhea, worst abdominal pain that patient have ever had and patient have IBS-M that was well controlled. This happened within 6 hours of the vaccine. Developed an infection with pus discharge in left bicep where the injection was given. AE resulted in Doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of adverse events and included treatment Anti-diarrheal, anti-spasmodic, antibiotic. The outcome of events was recovered with sequel.  No follow-up attempts are possible. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain
Clinical narrative: Mild chest pain that comes and goes; This is a spontaneous report from a contactable consumer (patient herself). A 25-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection and Lot Number: EW0161), via an unspecified route of administration on 22Apr2021 14:30 as dose number unknown, single for COVID-19 immunisation. Medical history included known allergies: Penicillin. Patient concomitant medications were reported as none. She was not pregnant at the time of vaccination. She did not take any other vaccine in four weeks and other medications in two weeks before COVID-19 vaccine. She was not tested with COVID-19 prior and post vaccination. On 23Apr2021, the patient experienced mild chest pain that comes and goes. Patient did not receive any treatment for event. The seriousness of the event was reported as non-serious. The outcome of the event was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Body temperature, Cardiovascular disorder, Dizziness, Dyspnoea
Clinical narrative: dizziness; problems with breathing; low blood pressure; slow blood circulation; Icy hands; hands are shaking; fever 101.3F; This is a spontaneous report from a contactable consumer. A 40-years-old female patient received bnt162b2 (Formulation: Solution for injection; Batch/Lot Number: ER8735), dose 2 via an unspecified route of administration, administered in Arm Left on 23Apr2021 08:45 as dose 2, single for covid-19 immunisation. Medical history included allergy to eggs from an unknown date and unknown if ongoing and patient was completed healthy. There were no concomitant medications. The patient previously received first dose of bnt162b2, via an unspecified route of administration, administered in Arm Left on 02Apr2021 09:00 AM as dose 1, single for covid-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not received any other medications within 2 weeks of vaccination. On 23Apr2021 08:45 patient experienced 30 minutes later after vaccination: dizziness, problems with breathing, low blood pressure, slow blood circulation- icy hands, hands are shaking 30 minutes. 12 hours later fever 101.3F. Patient received treatment put patient on wheelchair, hold head down, brought on fresh air, give something warm in the hands. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient underwent lab tests and procedures which included blood pressure measurement: low on 23Apr2021, body temperature: 101.3 fahrenheit on 23Apr2021, Nasal Swab: negative on 17Oct2020, Nasal Swab: negative on 02Feb2021. The outcome of the event was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Hypotension, Peripheral coldness, Pyrexia, SARS-CoV-2 test, Tremor
Clinical narrative: dizziness; problems with breathing; low blood pressure; slow blood circulation; Icy hands; hands are shaking; fever 101.3F; This is a spontaneous report from a contactable consumer. A 40-years-old female patient received bnt162b2 (Formulation: Solution for injection; Batch/Lot Number: ER8735), dose 2 via an unspecified route of administration, administered in Arm Left on 23Apr2021 08:45 as dose 2, single for covid-19 immunisation. Medical history included allergy to eggs from an unknown date and unknown if ongoing and patient was completed healthy. There were no concomitant medications. The patient previously received first dose of bnt162b2, via an unspecified route of administration, administered in Arm Left on 02Apr2021 09:00 AM as dose 1, single for covid-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not received any other medications within 2 weeks of vaccination. On 23Apr2021 08:45 patient experienced 30 minutes later after vaccination: dizziness, problems with breathing, low blood pressure, slow blood circulation- icy hands, hands are shaking 30 minutes. 12 hours later fever 101.3F. Patient received treatment put patient on wheelchair, hold head down, brought on fresh air, give something warm in the hands. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient underwent lab tests and procedures which included blood pressure measurement: low on 23Apr2021, body temperature: 101.3 fahrenheit on 23Apr2021, Nasal Swab: negative on 17Oct2020, Nasal Swab: negative on 02Feb2021. The outcome of the event was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Urticaria
Clinical narrative: I went for a run/jog and and I was short of breath and hives on my face and lips. The shortness of breath was scary as I was really unable to breath; I went for a run/jog and and I was short of breath and hives on my face and lips. The shortness of breath was scary as I was really unable to breath; This is a spontaneous report received from a contactable consumer (Patient). A 20-year-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EN6203), Solution for injection, via an unspecified route of administration on 08Apr2021 (at the age of A 20-year-old) as single dose for covid-19 immunisation. Medical history included asthma and nuts allergy. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medication within 2 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 Prior to vaccination. The patient had not been tested for COVID-19 Since the vaccination. On 19Apr2021, the patient went for a run/jog and she was short of breath and hives on her face and lips. The shortness of breath was scary as she was really unable to breath. Patient received children's Benadryl as a therapeutic measure to treat adverse event. The events was recovered on an unspecified date in Apr2021.  No follow-up attempts are possible. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: This is a spontaneous report from a contactable other healthcare professional from Pfizer. A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number and expiry date was not reported), via an unspecified route of administration on an unspecified date as dose number unknown, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unknown date, the reporter gave Pfizer vaccine to a patient and they said their face hand and back felt numb. The patient had the numbness for an hour until they left the clinic and patient was urged to go to urgent care but refused. So, the reporter wanted to know, what was the protocol they should follow for numbness. The outcome of the event was unknown. No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chest discomfort, Costochondritis, Dyspnoea, Fatigue
Clinical narrative: Chest tightness; Shortness of breath; Fever; Fatigue; Muscle and joint pain; Muscle and joint pain; Brain fog; nausea; headache; costochondritis; random pain in both upper extremities; This is a spontaneous report received from a contactable consumer or other non-health care professional (patient). A 35-years-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: Ew0153), via an unspecified route of administration, administered in Arm Right on 23Mar2021 13:30 as dose 1, single and a second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: En6207), via an unspecified route of administration, administered in Arm Right on 13Apr2021 13:30 (both doses at the age of 35-years-old) as dose 2, single for COVID-19 immunisation. Medical history included attention deficit hyperactivity (ADD), asthma, intervertebral disc degeneration from an unknown date and unknown if ongoing. Concomitant medications included ibuprofen (IBUPROFEN), beclometasone dipropionate (QVAR) Inhaler, amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) taken for an unspecified indication, start and stop date were not reported. Patient had no Known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, was the patient did not diagnosed with COVID-19. Since the vaccination, did not patient been tested for COVID-19. The patient experienced, on 13Apr2021 16:30, chest tightness, shortness of breath, fever, fatigue, muscle and joint pain, brain fog, nausea, headache that persisted until 17Apr2021 and costochondritis pain began 16Apr2021 and diagnosed on 20Apr2021, and is still persisting along with intermittent brain fog, fatigue, and random pain in both upper extremities. Treatment was received for the events as Albuterol, ibuprofen, declined oral prednisone. Patient visited Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The outcome of the events was reported as not recovered.  No follow-up attempt are possible. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Headache, Myalgia, Nausea, Pain in extremity
Clinical narrative: Chest tightness; Shortness of breath; Fever; Fatigue; Muscle and joint pain; Muscle and joint pain; Brain fog; nausea; headache; costochondritis; random pain in both upper extremities; This is a spontaneous report received from a contactable consumer or other non-health care professional (patient). A 35-years-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: Ew0153), via an unspecified route of administration, administered in Arm Right on 23Mar2021 13:30 as dose 1, single and a second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: En6207), via an unspecified route of administration, administered in Arm Right on 13Apr2021 13:30 (both doses at the age of 35-years-old) as dose 2, single for COVID-19 immunisation. Medical history included attention deficit hyperactivity (ADD), asthma, intervertebral disc degeneration from an unknown date and unknown if ongoing. Concomitant medications included ibuprofen (IBUPROFEN), beclometasone dipropionate (QVAR) Inhaler, amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) taken for an unspecified indication, start and stop date were not reported. Patient had no Known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, was the patient did not diagnosed with COVID-19. Since the vaccination, did not patient been tested for COVID-19. The patient experienced, on 13Apr2021 16:30, chest tightness, shortness of breath, fever, fatigue, muscle and joint pain, brain fog, nausea, headache that persisted until 17Apr2021 and costochondritis pain began 16Apr2021 and diagnosed on 20Apr2021, and is still persisting along with intermittent brain fog, fatigue, and random pain in both upper extremities. Treatment was received for the events as Albuterol, ibuprofen, declined oral prednisone. Patient visited Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The outcome of the events was reported as not recovered.  No follow-up attempt are possible. No further information is expected.